Ultrasound Enhancing Agents In the COVID-19 Era: Protocols, Safety, & Impact – SDMS

Current Status
Not Enrolled
Get Started

The current COVID-19 pandemic has raised interest in whether there are changes in either the role or safety of ultrasound enhancing agents (UEAs) in echocardiography. This Webinar from experts in the practice of contrast echocardiography will address:

  1. The impact of UEAs in patients with known or suspected COVID-19.
  2. Modifications to standard protocols for performing contrast ultrasound on patients who are in high-risk isolation settings.
  3. Safety of UEAs in patients who are critically ill or who are known to have COVID-19.
  1. Recognize situations where ultrasound enhancing agents (UEAs) are likely to have a clinical impact on the general population and on patients with known or suspected COVID-19.
  2. Be able to apply procedural modifications for efficient and safe use of (UEAs) in COVID-19 patients who are in isolation and at high risk for transmitting the disease.
  3. Understand the biologic basis underlying safety of (UEAs) and how they apply to the COVID-19 setting.

This program has been designed for sonographers, and other healthcare professionals involved in echocardiography.

This program has been submitted for approval of 0.75 SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Available from 5-7-2020 – 5-7-2021

Submitted for approval of 0.75 SDMS CME Credit Category AE


As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Jonathan R. Lindner, MD, FACC, FASE

  • NIH: R01-HL0178610, R01-HL130046, and P51-OD011092
  • NASA: 18-18HCFBP_2-0009
  • Investigator-initiated research grants from Lantheus, Ekos, GE

Thomas R. Porter, MD, FACC, FASE

  • Speaker: Northwest Imaging Forums
  • Consultant: Lantheus Medical
  • Research Equipment Support: Philips Healthcare

Michelle Bierig, PhD, ACS, RDCS, RCS, CPHQ, FASE, AACC – reported no relevant relationships with entities producing health care goods or services.

In Corporation with
To claim your credit please click on the Take this Course button above.
Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.